View in EDS PDF Full Text

Consensus molecular subtype 4 (CMS4)-targeted therapy in primary colon cancer: A proof-of-concept study.

Saved in:
Bibliographic Details
Title: Consensus molecular subtype 4 (CMS4)-targeted therapy in primary colon cancer: A proof-of-concept study.
Authors: Peters NA; Lab Translational Oncology, Division of Imaging and Cancer, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands., Constantinides A; Lab Translational Oncology, Division of Imaging and Cancer, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands., Ubink I; Lab Translational Oncology, Division of Imaging and Cancer, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands., van Kuik J; Department of Pathology, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands., Bloemendal HJ; Department of Internal Medicine, Meander Medical Center, Amersfoort, Netherlands.; Department of Internal Medicine/Oncology, Radboud University Medical Center Nijmegen, Nijmegen, Netherlands., van Dodewaard JM; Department of Internal Medicine, Meander Medical Center, Amersfoort, Netherlands., Brink MA; Department of Gastroenterology, Meander Medical Center, Amersfoort, Netherlands., Schwartz TP; Department of Gastroenterology, Meander Medical Center, Amersfoort, Netherlands., Lolkema MPJK; Department of Medical Oncology, Erasmus Medical Center, Rotterdam, Netherlands., Lacle MM; Department of Pathology, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands., Moons LM; Department of Gastroenterology, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands., Geesing J; Department of Gastroenterology, Diakonessenhuis, Utrecht, Netherlands., van Grevenstein WMU; Department of Surgical Oncology, Division of Imaging and Cancer, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands., Roodhart JML; Lab Translational Oncology, Division of Imaging and Cancer, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands., Koopman M; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands., Elias SG; Julius Centre for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands., Borel Rinkes IHM; Lab Translational Oncology, Division of Imaging and Cancer, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.; Department of Surgical Oncology, Division of Imaging and Cancer, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands., Kranenburg O; Lab Translational Oncology, Division of Imaging and Cancer, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.
Source: Frontiers in oncology [Front Oncol] 2022 Sep 06; Vol. 12, pp. 969855. Date of Electronic Publication: 2022 Sep 06 (Print Publication: 2022).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 36147916
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Consensus molecular subtype 4 (CMS4)-targeted therapy in primary colon cancer: A proof-of-concept study.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Peters+NA%22">Peters NA</searchLink>; Lab Translational Oncology, Division of Imaging and Cancer, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.<br /><searchLink fieldCode="AU" term="%22Constantinides+A%22">Constantinides A</searchLink>; Lab Translational Oncology, Division of Imaging and Cancer, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.<br /><searchLink fieldCode="AU" term="%22Ubink+I%22">Ubink I</searchLink>; Lab Translational Oncology, Division of Imaging and Cancer, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.<br /><searchLink fieldCode="AU" term="%22van+Kuik+J%22">van Kuik J</searchLink>; Department of Pathology, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.<br /><searchLink fieldCode="AU" term="%22Bloemendal+HJ%22">Bloemendal HJ</searchLink>; Department of Internal Medicine, Meander Medical Center, Amersfoort, Netherlands.; Department of Internal Medicine/Oncology, Radboud University Medical Center Nijmegen, Nijmegen, Netherlands.<br /><searchLink fieldCode="AU" term="%22van+Dodewaard+JM%22">van Dodewaard JM</searchLink>; Department of Internal Medicine, Meander Medical Center, Amersfoort, Netherlands.<br /><searchLink fieldCode="AU" term="%22Brink+MA%22">Brink MA</searchLink>; Department of Gastroenterology, Meander Medical Center, Amersfoort, Netherlands.<br /><searchLink fieldCode="AU" term="%22Schwartz+TP%22">Schwartz TP</searchLink>; Department of Gastroenterology, Meander Medical Center, Amersfoort, Netherlands.<br /><searchLink fieldCode="AU" term="%22Lolkema+MPJK%22">Lolkema MPJK</searchLink>; Department of Medical Oncology, Erasmus Medical Center, Rotterdam, Netherlands.<br /><searchLink fieldCode="AU" term="%22Lacle+MM%22">Lacle MM</searchLink>; Department of Pathology, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.<br /><searchLink fieldCode="AU" term="%22Moons+LM%22">Moons LM</searchLink>; Department of Gastroenterology, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.<br /><searchLink fieldCode="AU" term="%22Geesing+J%22">Geesing J</searchLink>; Department of Gastroenterology, Diakonessenhuis, Utrecht, Netherlands.<br /><searchLink fieldCode="AU" term="%22van+Grevenstein+WMU%22">van Grevenstein WMU</searchLink>; Department of Surgical Oncology, Division of Imaging and Cancer, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.<br /><searchLink fieldCode="AU" term="%22Roodhart+JML%22">Roodhart JML</searchLink>; Lab Translational Oncology, Division of Imaging and Cancer, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.<br /><searchLink fieldCode="AU" term="%22Koopman+M%22">Koopman M</searchLink>; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.<br /><searchLink fieldCode="AU" term="%22Elias+SG%22">Elias SG</searchLink>; Julius Centre for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.<br /><searchLink fieldCode="AU" term="%22Borel+Rinkes+IHM%22">Borel Rinkes IHM</searchLink>; Lab Translational Oncology, Division of Imaging and Cancer, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.; Department of Surgical Oncology, Division of Imaging and Cancer, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.<br /><searchLink fieldCode="AU" term="%22Kranenburg+O%22">Kranenburg O</searchLink>; Lab Translational Oncology, Division of Imaging and Cancer, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101568867%22">Frontiers in oncology</searchLink> [Front Oncol] 2022 Sep 06; Vol. 12, pp. 969855. <i>Date of Electronic Publication: </i>2022 Sep 06 (<i>Print Publication: </i>2022).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101568867 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2234-943X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222234943X%22">2234943X </searchLink><i>NLM ISO Abbreviation: </i>Front Oncol <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36147916
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fonc.2022.969855
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 969855
    Titles:
      – TitleFull: Consensus molecular subtype 4 (CMS4)-targeted therapy in primary colon cancer: A proof-of-concept study.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Peters NA
      – PersonEntity:
          Name:
            NameFull: Constantinides A
      – PersonEntity:
          Name:
            NameFull: Ubink I
      – PersonEntity:
          Name:
            NameFull: van Kuik J
      – PersonEntity:
          Name:
            NameFull: Bloemendal HJ
      – PersonEntity:
          Name:
            NameFull: van Dodewaard JM
      – PersonEntity:
          Name:
            NameFull: Brink MA
      – PersonEntity:
          Name:
            NameFull: Schwartz TP
      – PersonEntity:
          Name:
            NameFull: Lolkema MPJK
      – PersonEntity:
          Name:
            NameFull: Lacle MM
      – PersonEntity:
          Name:
            NameFull: Moons LM
      – PersonEntity:
          Name:
            NameFull: Geesing J
      – PersonEntity:
          Name:
            NameFull: van Grevenstein WMU
      – PersonEntity:
          Name:
            NameFull: Roodhart JML
      – PersonEntity:
          Name:
            NameFull: Koopman M
      – PersonEntity:
          Name:
            NameFull: Elias SG
      – PersonEntity:
          Name:
            NameFull: Borel Rinkes IHM
      – PersonEntity:
          Name:
            NameFull: Kranenburg O
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 06
              M: 09
              Text: 2022 Sep 06
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-print
              Value: 2234-943X
          Numbering:
            – Type: volume
              Value: 12
          Titles:
            – TitleFull: Frontiers in oncology
              Type: main
ResultId 1